跳至主要内容

博文

目前显示的是标签为“Mesothelioma”的博文

Prognostic Value of Neutrophil Lymphocyte Ratio in Second Line Advanced Malignant Pleural Mesothelioma

Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=47102#.VGGJR2fHRK0 Author(s) Ahmed El Bastawisy , Maha Yahia , Abdel Rahman M. Abdel Rahman , Rabab Gaafar Affiliation(s) Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt . Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt . Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt . Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt . ABSTRACT Background: Malignant pleural mesothelioma is a lethal disease and hence the strong need for identifying new prognostic factors. Methods: This is a re...

Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival

Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50986#.VFHN_FfHRK0 Author(s) Stanislaw R. Burzynski , Tomasz J. Janicki , Gregory S. Burzynski , Sheldon Brookman Affiliation(s) Burzynski Clinic, Houston, TX, USA . ABSTRACT Advanced malignant mesothelioma (MM) is among the most aggressive and difficult-to-treat diseases. Industrialization and exposure to asbestos is the main causative factor for the dramatic increase in the incidence of MM, which carries a poor prognosis and a median survival of less than 12 months. Combination chemotherapy offers only palliative results; however, targeted therapy carries more promise for future successful treatment. This paper presents preliminar...